• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Abbott Unveils FreeStyle Libre 3 Plus: World’s Smallest CGM Sensor with Future AID Compatibility

by Jasmine Pennic 06/27/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– At the American Diabetes Association conference, Abbott unveiled a new addition to its FreeStyle Libre portfolio – the FreeStyle Libre 3 Plus sensor. 

– The sensor boasts the distinction of being the world’s smallest, thinnest, and most discreet continuous glucose monitoring (CGM) sensor available.

Unmatched Design and Performance

The FreeStyle Libre 3 Plus sensor offers a unique combination of user-centric features:

  • Unmatched Discreetness: The sensor maintains the same size as the original Libre 3 sensor, making it about the size of two stacked pennies. This ensures exceptional comfort and discreet wear for users.
  • Extended Wear Time: The sensor offers a wear time of 15 days, eliminating the need for frequent replacements.
  • Future-Proof Technology: The Libre 3 Plus is designed for future compatibility with automated insulin delivery (AID) systems, empowering seamless integration with advanced diabetes management solutions as they become available.

Improved User Experience

The sensor streamlines glucose monitoring for users:

  • No Scanning Required: Gone are the days of finger pricking or scanning. When paired with the FreeStyle Libre 3 app or reader, the sensor automatically transmits glucose data to the smartphone, providing real-time readings with no additional action required.
  • Real-Time Glucose Data: The sensor measures glucose levels every minute and transmits updates to the app at the same frequency, offering a complete picture of glucose trends.

Availability

The FreeStyle Libre 3 Plus sensor will be available in the coming months at U.S. retail pharmacies and participating durable medical equipment (DME) suppliers.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Continuous Glucose Monitoring (CGM), Diabetes Management, Diabetes Management Platform

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Research Report

2026 Best in KLAS Awards: The Full List of Software & Services Winners

2026 Predictions & Trends

Healthcare 2026 Forecast: Executives on AI Survival, Financial Reckoning, and the End of Point Solutions

2026 Healthcare Executive Predictions: Why the AI “Pilot Era” Is Officially Over

Most-Read

The "Platform" Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

The “Platform” Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

Analysis: Oracle Cerner’s Plans for a National EHR

Oracle May Cut 30k Jobs and Sell Cerner to Fund $156B OpenAI Deal

The $1.9B Exit: Why CommonSpirit is Insourcing Revenue Cycle and Tenet is Betting Big on Conifer AI

The $1.9B Exit: Why CommonSpirit is Insourcing Revenue Cycle and Tenet is Betting Big on Conifer AI

KLAS 2026 Rankings: Aledade and Guidehealth Named Top VBC Enablement Firms

KLAS 2026 Rankings: Aledade and Guidehealth Named Top VBC Enablement Firms

Beyond the Hype: New KLAS Data Validates the Financial and Clinical ROI of Ambient AI

Beyond the Hype: New KLAS Data Validates the Financial and Clinical ROI of Ambient AI

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

OpenAI Debuts ChatGPT Health: A ‘Digital Front Door’ That Connects Medical Records to Agentic AI

OpenAI Debuts ChatGPT Health: A ‘Digital Front Door’ That Connects Medical Records to Agentic AI

From Genes to Hackers: The Hidden Cybersecurity Risks in Life Sciences

From Genes to Hackers: The Hidden Cybersecurity Risks in Life Sciences

Utah Becomes First State to Approve AI System for Prescription Renewals

Utah Becomes First State to Approve AI System for Prescription Renewals

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |